ACRHDAdvisory Committee for Reproductive Health Drugs
References in periodicals archive ?
The ACRHD will discuss the use of denosumab in each of four indications outlined in the BLAs:
Denosumab has a positive benefit:risk profile in these patient populations, and we look forward to discussing our data with the ACRHD today," Perlmutter said.
The FDA often seeks the advice of an advisory committee such as the ACRHD when evaluating a potential new treatment but is not required to follow its recommendation.